KR102701883B1 - 천연 복합 추출물을 포함하여 광 보호 효과를 갖는 조성물 및 이를 포함하는 화장료 조성물 - Google Patents
천연 복합 추출물을 포함하여 광 보호 효과를 갖는 조성물 및 이를 포함하는 화장료 조성물 Download PDFInfo
- Publication number
- KR102701883B1 KR102701883B1 KR1020240051280A KR20240051280A KR102701883B1 KR 102701883 B1 KR102701883 B1 KR 102701883B1 KR 1020240051280 A KR1020240051280 A KR 1020240051280A KR 20240051280 A KR20240051280 A KR 20240051280A KR 102701883 B1 KR102701883 B1 KR 102701883B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- bark
- tree
- uva
- extracted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 239000000284 extract Substances 0.000 title claims abstract description 29
- 230000003711 photoprotective effect Effects 0.000 title claims abstract description 28
- 239000002537 cosmetic Substances 0.000 title claims abstract description 20
- 235000004422 Acer negundo Nutrition 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 235000010181 horse chestnut Nutrition 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 7
- 239000008213 purified water Substances 0.000 claims description 6
- 241000157280 Aesculus hippocastanum Species 0.000 claims description 5
- 241000208140 Acer Species 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 13
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 abstract description 9
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 abstract description 8
- 244000046151 Acer negundo Species 0.000 abstract description 6
- 230000037373 wrinkle formation Effects 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 230000030833 cell death Effects 0.000 abstract description 2
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 17
- 238000000605 extraction Methods 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- 230000003833 cell viability Effects 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 241000157282 Aesculus Species 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- -1 fractions Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000012981 Hank's balanced salt solution Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000037380 skin damage Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000588214 Fraxinus chinensis subsp. rhynchophylla Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 241000207834 Oleaceae Species 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940100573 methylpropanediol Drugs 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 238000003026 viability measurement method Methods 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 235000007237 Aegopodium podagraria Nutrition 0.000 description 1
- 244000045410 Aegopodium podagraria Species 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 235000014429 Angelica sylvestris Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 241001536358 Fraxinus Species 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
도 1a는 실험예 1에서 측정된 실시예와 비교예 1 내지 4의 세포 생존능력 측정 결과를 그래프로 나타낸 것이다.
도 1b는 실험예 1에서 측정된 실시예와 비교예 5 내지 7의 세포 생존능력 측정 결과를 그래프로 나타낸 것이다.
도 2는 실험예 2에서 측정된 실시예의 MMP-1 인자 발현량 측정 결과를 그래프로 나타낸 것이다.
Claims (8)
- 천연 복합 추출물을 포함함으로써 UVA에 대한 광 보호 효과를 갖는 조성물에 있어서,
상기 천연 복합 추출물은, 가시칠엽수(Aesculus hippocastanum) 및 물푸레나무 껍질로부터 추출되며,
상기 가시칠엽수 및 물푸레나무 껍질은, 1.5 내지 2.5 : 1의 중량비로 혼합되어 추출되는, 조성물. - 삭제
- 제 1 항에 있어서,
상기 가시칠엽수 및 물푸레나무 껍질은, 2 : 1의 중량비로 혼합되어 추출되는, 조성물. - 제 1 항에 있어서,
상기 가시칠엽수는, 가시칠엽수 가지를 포함하는, 조성물. - 제 1 항에 있어서,
상기 가시칠엽수 및 물푸레나무 껍질은, 정제수를 용매로 하여 추출된 것을 포함하는, 조성물. - 제 1 항에 있어서,
상기 조성물은, 상기 천연 복합 추출물을 230μg/ml 이하의 농도로 포함하는, 조성물. - 제 1 항 및 제 3 항 내지 제 6 항 중 어느 한 항에 따른 조성물을 포함하는, 화장료 조성물.
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020240051280A KR102701883B1 (ko) | 2024-04-17 | 2024-04-17 | 천연 복합 추출물을 포함하여 광 보호 효과를 갖는 조성물 및 이를 포함하는 화장료 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020240051280A KR102701883B1 (ko) | 2024-04-17 | 2024-04-17 | 천연 복합 추출물을 포함하여 광 보호 효과를 갖는 조성물 및 이를 포함하는 화장료 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102701883B1 true KR102701883B1 (ko) | 2024-09-04 |
Family
ID=92760086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020240051280A Active KR102701883B1 (ko) | 2024-04-17 | 2024-04-17 | 천연 복합 추출물을 포함하여 광 보호 효과를 갖는 조성물 및 이를 포함하는 화장료 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102701883B1 (ko) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009132651A (ja) * | 2007-11-30 | 2009-06-18 | Club Cosmetics Co Ltd | 紫外線防御剤 |
KR101856374B1 (ko) | 2016-10-26 | 2018-05-11 | 에스케이바이오랜드 주식회사 | 증숙 가시오가피 뿌리 추출물을 함유하는 피부 광손상 보호용 화장료 조성물 |
KR20190050415A (ko) * | 2017-11-03 | 2019-05-13 | 주식회사 코씨드바이오팜 | 물푸레나무 추출물을 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물 |
KR20210010160A (ko) * | 2019-07-19 | 2021-01-27 | 주식회사 케미랜드 | 물푸레나무 유래 신규 쿠마린계 화합물의 제조방법 및 주름 개선용 화장료 조성물 |
-
2024
- 2024-04-17 KR KR1020240051280A patent/KR102701883B1/ko active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009132651A (ja) * | 2007-11-30 | 2009-06-18 | Club Cosmetics Co Ltd | 紫外線防御剤 |
KR101856374B1 (ko) | 2016-10-26 | 2018-05-11 | 에스케이바이오랜드 주식회사 | 증숙 가시오가피 뿌리 추출물을 함유하는 피부 광손상 보호용 화장료 조성물 |
KR20190050415A (ko) * | 2017-11-03 | 2019-05-13 | 주식회사 코씨드바이오팜 | 물푸레나무 추출물을 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물 |
KR20210010160A (ko) * | 2019-07-19 | 2021-01-27 | 주식회사 케미랜드 | 물푸레나무 유래 신규 쿠마린계 화합물의 제조방법 및 주름 개선용 화장료 조성물 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Desam et al. | The importance of natural products in cosmetics | |
KR101632916B1 (ko) | 보리수나무 추출물을 포함하는 천연 방부제 조성물 | |
KR101928386B1 (ko) | 피부색보정, 자외선차단, 주름개선 및 미백 기능을 가지는 크림 제형 화장품의 혼합 조성물 및 제조방법 | |
KR102128974B1 (ko) | 여주, 감나무잎 및 비단풀의 복합추출물을 유효성분으로 포함하는 자외선에 대한 피부 보호용 화장료 조성물 | |
KR102271886B1 (ko) | 한방복합조성물을 유효성분으로 함유하는 기능성 화장료 조성물 | |
FI20205713A1 (en) | Cosmetic compositions comprising Nordic plant derived ingredients and a mild neutralizing agent | |
WO2005034894A1 (ja) | 育毛剤組成物 | |
KR102164246B1 (ko) | 식물 복합 추출물을 유효성분으로 포함하는 항산화 및 자외선에 대한 피부 보호용 화장료 조성물 | |
KR100517465B1 (ko) | 아토피 피부용 한방 화장료 조성물 | |
JP2006069954A (ja) | チロシナーゼ活性阻害剤、美白剤及び皮膚化粧料 | |
KR102087976B1 (ko) | 물푸레나무 추출물을 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물 | |
KR102447999B1 (ko) | 티트리잎, 페퍼민트잎, 약모밀, 녹차, 노니 및 파슬리의 혼합 추출물을 유효성분으로 함유하는 피부 탄력 개선용 화장료 조성물 | |
KR102278167B1 (ko) | 지질산화 방지, 자외선에 의한 손상 피부 개선 및 피부 진정 효과가 우수한 화장료 조성물 | |
KR102701883B1 (ko) | 천연 복합 추출물을 포함하여 광 보호 효과를 갖는 조성물 및 이를 포함하는 화장료 조성물 | |
KR20150141078A (ko) | 노인 악취 제거 조성물 | |
EP4389136A1 (fr) | Composition neurocosmetique pour prevenir les effets du stress | |
KR101969475B1 (ko) | 엉겅퀴를 포함하는 복합 식물의 추출물을 유효성분으로 포함하는 피부개선용 화장료 조성물 | |
JP2006052198A (ja) | デオドラント剤、デオドラント製剤、および繊維デオドラント処理方法 | |
KR20170122315A (ko) | 미선나무 추출액을 이용한 피부용 화장료 조성물 | |
KR20200034570A (ko) | 구취제거용 조성물 | |
JP2006052198A5 (ko) | ||
KR101617730B1 (ko) | 인삼열매, 포도씨 추출물을 포함하는 화장료 조성물 및 이를 이용한 화장품 | |
JP2015086168A (ja) | リパーゼ阻害剤および皮脂コントロール用皮膚化粧料 | |
KR102246846B1 (ko) | 천년초 추출물을 유효성분으로 포함하는 안티폴루션 화장료 조성물 | |
KR102714334B1 (ko) | 꽃송이버섯 추출물, 방사무늬돌김 추출물 및 해바라기싹 추출물을 포함하는 자외선 차단 보조제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20240417 |
|
PA0201 | Request for examination |
Patent event code: PA02011R01I Patent event date: 20240417 Comment text: Patent Application |
|
PA0302 | Request for accelerated examination |
Patent event date: 20240418 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20240618 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20240827 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20240828 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20240829 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration |